SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.
Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.
National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.
Paulette Gray named director of NCI Division of Extramural Activities.
Trending Stories
- “All in Her Head” catalogs the history of medicine’s atrocities against women
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - Chernobyl: a 35 year follow up on long-term health effects
- Suspensions, public outrage ensue as tensions over Middle East sweep through oncology
NYU Cancer Center Director Benjamin Neel suspended over social media posts - What are you reading in 2024?
- Prominent GI oncologist Axel Grothey was forced out of Mayo Clinic for unethical sexual relationships with women he mentored
Three reprimands later, he retains leadership—and mentorship—positions